LEP and differentiated thyroid carcinoma: Leptin and its derivative, OB3, both significantly reduce abundance of MMP9 mRNA in follicular thyroid cancer cells (Figure 4B), but do not affect expression of MMP9 in papillary thyroid carcinoma cells (Figure 4A).